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Abstract
Background: Lung cancer is the leading cause of cancer death in Australia. There is potential that health
promotion about the risks and warning signs of lung cancer could be used to reduce delays in symptom
presentation when symptoms are first detected. This study investigated knowledge, attitudes and beliefs which
might impact help-seeking behaviour and could provide insight into possible public health interventions in New
South Wales (NSW).
Methods: A convergent mixed method study design was used wherein data from 16 qualitative focus groups of
residents (40+ years), purposefully recruited and stratified by smoking status, age and geography (metropolitan/
regional), were compared with a CATI administered population-wide telephone survey (n = 1,000) using the Cancer
Research UK cancer awareness measure (LungCAM). Qualitative findings were analysed thematically using NVIVO.
Logistic regression analysis was used to investigate predictors of symptom knowledge in STATA. Findings were
integrated using triangulation techniques.
Results: Across focus groups, haemoptysis was the only symptom creating a sense of medical urgency. Life
experiences evoked a ‘wait and see’ attitude to any health deterioration. Perceived risk was low amongst those at
risk with current smokers preferring to deny their risk while former smokers were generally unaware of any ongoing
risk. The quantitative sample consisted of females (62 %), 40–65 years (53 %), low SES (53 %), former (46 %) and
current smokers (14 %). In quantitative findings, haemoptysis and dyspnoea were the most recognised symptoms
across the sample population. Age (<65 years), sex (female) and high socio-economic status contributed to a higher
recognition of symptoms. Smoking was recognised as a cause of lung cancer, yet ever-smokers were less likely to
recognise the risk of lung cancer due to second-hand smoke (OR 0.7 95 % CI 0.5–0.9).
Conclusion: While there was some recognition of risk factors and symptoms indicative of lung cancer, there was
disparity across the sample population. The qualitative findings also suggest that knowledge may not lead to earlier
presentation; a lack of urgency about symptoms considered trivial, and smoking-related barriers such as stigma may
also contribute to time delays in presentation. Public health interventions may be required to increase awareness of
risk and emphasise the importance of seeking medical attention for ongoing symptoms.
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Background
In Australia lung cancer is the leading cause of cancer
death for both males and females [1]. Lung cancer sur-
vival has improved little over the past thirty years and
there are wide international inequalities in survival rates
[2]. The five-year relative survival rate for lung cancer is
poor at 16 % and in most cases diagnose of lung cancer
occurs late, predominantly in Stage III or IV [3]. Earlier
detection and diagnosis of lung cancer can lead to im-
proved outcomes in survival rates [4, 5].
One key factor contributing to poorer outcomes for
some people with lung cancer is delay in the time it
takes to present symptoms from when they are first de-
tected [6–8]. While some people remain asymptomatic
until lung cancer is well advanced, others may fail to
recognise the seriousness of symptoms experienced,
attribute symptoms to existing comorbidity or fail to
report changes to their doctor [6, 7, 9]. In addition,
people may delay help-seeking due to poor knowledge of
lung cancer symptoms, not recognising them as being
indicative of a serious disease [10, 11], or wait until their
symptoms reach a crisis point [6, 7, 9, 12–14]. Lack of
public awareness of lung cancer and recognition of
what to do when symptoms develop can contribute to
this delay [15].
Evidence also suggests that long-term smoking con-
tributes to delays in the time it takes people to seek
medical help [7] and that this may be due in part to fear
of blame and the stigma attached to smoking [16, 17] or
attributing the symptoms to smoking itself [11]. A syn-
thesis of research into patients’ experiences of recognis-
ing symptoms of cancer and help-seeking found that the
patient’s gender and the sanctioning of help-seeking
were important factors in prompt consultation [12].
While community awareness of the link between
smoking and lung cancer in Australia is high [18],
awareness of lung cancer symptom recognition is un-
known. A number of studies have identified certain
symptoms to be more prevalent at various stages of the
disease development. For example, symptoms of cough
have been reported more frequently in the earlier stages
of lung cancer (stage I-III) [7, 19]. Other findings suggest
that patients possibly ignore symptoms particularly a
persistent cough [7, 9]. It is possible that public
knowledge of lung cancer symptoms and therefore
ability to recognise symptoms may be higher regarding
late stage symptoms such as haemoptysis and less so
about symptoms which might appear earlier because
of the timing of the symptoms and connection with
diagnosis [19].
In New South Wales(NSW), the largest State of
Australia, lung cancer is the fourth most common can-
cer and the leading cause of cancer death [1]. At the
State level, health promotion interventions aiming to
reduce the incidence of cancer and increase cancer sur-
vival are an important component of the NSW Cancer
Plan [20]. The primary aim of this study was to compre-
hensively investigate current knowledge of risk factors
and symptoms suggestive of lung cancer in NSW and




A convergent parallel mixed-method design utilising
quantitative and qualitative data collected in 2012 was
used to investigate knowledge, attitudes and beliefs
which may influence behaviours in relation to lung
cancer symptoms, diagnosis and treatment. The mixed
method design provided multiple perspectives on the
issue [21].
Source and study population
Participants in both the qualitative and quantitative
study components were male and female, aged over
40 years, resided in metropolitan or regional areas of
NSW. NSW is the most populous State of Australia with
an estimated population of 7.4 million people. The ma-
jority of residents in NSW live in greater Sydney. It is es-
timated that 50.4 % of the current adult population in
NSW has never smoked, while 15.6 % of the population
currently smoke [22].
The qualitative research comprised of 16 mixed gender
focus groups (7–8 participants) (n = 126) (Table 1).
Quota sampling was used to select and segment partici-
pants by smoking status, age, and socio-economic status
(geography-income) (Table 2) as knowledge may differ
across these groups. Participants were recruited from a
large market research panel where they had opted to be
contacted for social marketing research, and were
approached via email/telephone. This method allowed
for rapid recruitment of a diverse range of people. No
prior disclosure of the topic was provided to prevent
contamination of participant knowledge.
Participants (n = 1,000), in the quantitative study
were recruited through a Random Digit Dialling
(RDD) sampling frame of landline telephone numbers
and selected using the ‘next-birthday’ method where
there was more than one eligible member in a house-
hold (i.e. the person with the next upcoming birthday
was selected where there was more than one eligible
person). Quotas were placed on the quantitative
sample to include a slightly higher sample of ever
smokers (60 %) [23]. This would allow for higher
powered sample to investigate relationships within the
ever-smoking sample, given the relative risk of lung
cancer associated with smoking [24].
Crane et al. BMC Public Health  (2016) 16:508 Page 2 of 12
Procedure
Qualitative research
Focus groups were used to explore lung cancer aware-
ness of sentinel symptoms and risk factors and beliefs
and attitudes. Personal risk, susceptibility and help-
seeking behaviours were also explored (Table 2). Focus
group discussions were facilitated by three experienced
and accredited qualitative interviewers and were semi-
structured using a discussion guide (Table 2). Focus
groups were conducted face-to-face in community func-
tion centre rooms in three metropolitan and three
regional locations in NSW. There were no non-
participants within the group discussions. Participants
provided written consent prior to the focus group dis-
cussion. With consent, the metropolitan groups were
covertly observed by the authors. Group discussions
were conducted for duration of 1.5 h, and participants
were reimbursed for their time.
Quantitative research
A cross-sectional survey was used to examine lung can-
cer symptom awareness and help seeking behaviour. The
Lung Cancer Awareness Measure (Lung-CAM) was used
as the survey instrument. The Lung-CAM is a validated
measure developed by University College London and
Cancer Research UK which is based on the generic
CAM, designed to assess awareness of cancer in the
general population [25]. The CAM has been used to
monitor awareness over time, compare between groups,
identify information needs, and monitor the impact of
awareness-raising interventions [26]. Surveys were ad-
ministered using Computer Assisted Telephone Inter-
viewing (CATI). The cross-cultural face validity of the
Lung-CAM was first tested in the Australian popula-
tion by pilot testing. No issues with the survey’s con-
tent or flow were encountered by participants.
Participant consent was obtained verbally and re-
corded. Those conducting the CATI were not aware
of the qualitative study findings to reduce the threat
of contamination.
Ethical approval was granted by the NSW Population
and Health Services Research Committee.
Measures/operational definitions
Age Age was split into two groups where possible (40–
64 years vs 65+), given the majority of lung cancer cases
occur after 65 years the knowledge of symptoms and risk
factors may differ as a consequence.
Socio-economic status (SES) Education and income
status were combined as one measure. High SES was de-
fined as a household income of more than AUD$80,000
(and any education level), or an income of AUD$40–
80,000 and moderate-high education. Moderate SES was
Table 1 Characteristics of the focus groups of NSW residents, Australia, 2012
Location SES Age group Never smoker Former smoker Current smoker
Metropolitan Low 40-64 years Group 6 Group 12 Group 11
65+ years Group 4 Group 3
Medium-high 40-64 years Group 1 Group 2
65+ years Group 5
Regional Low 40-64 years Group 9 Group 8 Group 10
65+ years Group 14
Medium-high 40-64 years Group 16 Group 13
65+ years Group 15 Group 7
Each group included 7-8 participants
Table 2 Focus group discussion guide
Discussion question Theme
What do you know about lung cancer? Knowledge about lung cancer, diagnosis, treatment,
prognosis
What do you think increases someone’s chance of developing lung cancer? Knowledge & perceptions about causes
Is there something you could do to reduce/prevent lung cancer? What do you think causes
lung cancer?
Knowledge & perceptions about causes
What symptoms and warning signs do you think could be associated with lung cancer? Knowledge & perceptions about sentinel symptoms
What do you think when you hear someone has lung cancer? Perceived severity and prognosis
Who do you think is most likely to develop lung cancer? Perceived risk & susceptibility
Do you think that you are at risk of developing lung cancer? Perceived risk & susceptibility
What would you do if you had symptoms consistent with lung cancer? Help-seeking behaviours
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defined as an income below AUD$40,000 and high edu-
cation, or an income of AUD$40–80,000 and moderate
education. Low SES was defined as an income below
AUD$40,000 and low or moderate education, or an in-
come AUD$40–80,000 and low education. Those with
missing data on one variable were classified based on
the other.
Location-SES Area postcode was used to determine
geographic location as metropolitan (Sydney) or re-
gional/rural location. Postcode was also used as an index
of relative socio-economic disadvantage which is a gen-
eral socio-economic index based on economic and social
conditions of people and households within an area [27].
In the qualitative study geographic location was deter-
mined by area postcode.
Smoking status Smoking status was defined as “ever
smoked daily or weekly” with a subsequent question
used to determine current status as a smoker [S],
former-smoker [ex-S] or never smoker [NS]. The num-
ber of years smoking a pack of cigarettes a day was used
as a rudimental measure of pack-years.
Lung cancer knowledge The Lung-CAM comprises of
28 items including knowledge of warning signs (other-
wise described as ‘sentinel’ symptoms indicative of lung
cancer or symptoms throughout), age of risk, risk factors
and behaviour regarding delay in seeking medical help
and confidence in detecting symptoms [25]. Two add-
itional questions were added to determine wider help-
seeking behaviours including “who would you go to for
help or advice”, and “how soon would you discuss it with
a family member, friend or partner” [if you had symp-
toms you thought might be a sign of lung cancer].
Knowledge definition Knowledge of symptoms and risk
factors for lung cancer was defined as correct identifica-
tion of a sentinel symptom or risk factor (unprompted).
Prompted responses were compared with unprompted
responses.
Knowledge covariates ‘Previous experience of cancer’ ei-
ther through personal experience of cancer, or through
the experience of close friends/relatives, was included as
binary yes/no covariant of knowledge.
Help seeking definition Quantitative participants were
asked how confident they were that they would notice a
symptom of lung cancer, who would they see if they had
a symptom and how soon they would contact their doc-
tor or family/friend to discuss a symptom. Qualitative
exploration of what participants would do, who they
would see, what symptoms they would seek help for.
Data collection & quality control
Qualitative and quantitative data were collected concur-
rently and separately. Focus group discussions were
audio recorded and de-identified verbatim transcripts
were provided to the researchers for data coding. To as-
sess data quality of the data and coding, we checked data
against field notes and checked meanings and nuances
with the focus group facilitators to reduce potential bias.
We also sought to minimise researcher bias in the cod-
ing, ensuring that more than one person contributed to
the coding.
The survey took an average of 11.1 min to complete,
and a response rate (RR3) of 44 % and cooperation rate
(CR3) of 88 % was achieved based on AAPOR eligibility
[28]. Quantitative data were collected and weighting
applied to adjust for age, sex and regional distribution
for population inferences [23]. Post weights were then
applied to adjust for differences in the proportion of
current smokers weighting to the National Drug Strategy
Household Survey, 2010 [29] for population level
inferences.
Analysis
Content and thematic analysis
First cycle qualitative data coding was carried out inde-
pendently by one author and compared with three
others who independently coded one third of the data
each. A deductive process was first applied to the coding
to investigate the predetermined themes. Patterns in the
data were then investigated from an inductive approach
to explore nuances and emerging constructs within the
data. The authors then all met to resolve any discrepan-
cies; validate identified themes and then interpret con-
textual meaning. Nvivo 10 software (QSR International
Pty Ltd. Version 10, 2014) was used to compare themes
and models. The credibility of the qualitative data was
compared with the literature, particularly findings from
a previous study which specifically explored lung cancer
knowledge and attitudes in culturally diverse communi-
ties in Australia [30]. The data was checked for repre-
sentativeness across the various demographic groupings.
Findings from the content and thematic analyses were
then synthesised and variations compared according to
theoretical groupings (age, location, socio-economic sta-
tus and smoking history).
Statistical analysis
Pearson’s χ2 test was used to test for differences in
proportions and t-tests to measure mean differences.
To describe demographic variations in lung cancer
knowledge, multiple logistic regression modelling
was used to analyse recognition of symptoms (with
recognition as a binary yes/no variable) based on
predictors of lung cancer and demographic variables
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(smoking history, age, experience of cancer, SES and
sex). Symptoms were modelled as follows: symptoms
that were recognised by the whole population were
modelled in the first model and then stratified ac-
cording to smoking status and modelled in ever
smokers only (this did not include rarer symptoms
such as finger clubbing or stridor). Pack years di-
vided at >20 years were included as a predictor in
the sub-analysis. In the second set of models only
cough symptoms were included as this was felt to
reflect the most frequently encountered early symp-
tom of lung cancer by participants and it may give
insight into characteristics of awareness at early
stages of lung cancer. Sensitivity analysis was used
to investigate specific and non-specific symptoms
(‘persistent’ ‘painful’ or ‘worsening’ cough verse an
unspecified cough). Confidence in recognising symp-
toms and seeking help for symptoms were also
analysed using logistic regression analysis and adjust-
ing for demographic covariates. Statistical analysis
was conducted using Stata version 11 (StataCorp LP,
College Station, TX).
Integration
Data were first analysed separately, and then compared.
Equal emphasis was given to both research components
[21, 31]. Where possible qualitative data was trans-
formed into count qualities and correlations with the
quantitative data investigated. Comparisons were taken
between the data sources using quantitative methods
and then compared using a qualitative approach. The
convergence of themes across the datasets was coded
and assessed using triangulation matrices to display and




In exploring participants’ knowledge about lung cancer
several themes arose. All groups could identify some senti-
nel symptoms correctly but there was a great deal of
uncertainty and most groups assessed that these symp-
toms were not necessarily a reason to suspect lung cancer.
“You can cough up blood and that’s something else,
probably”. -40–55, S, metro
“You’re guessing about a multitude of things between
your mouth and the bottom of your lungs, and there’s
any number of things that can make you bleed or
cough”. - 40–64, ex-S, regional
There was uncertainty about the relationship between
emphysema and lung cancer. Current smokers were
particularly confused about the difference, with many
believing that lung cancer was a progression from
emphysema.
"Isn't emphysema the start of lung cancer?" 40–65+,
S/Ex-S, metro/regional
Help-seeking
Whether knowledge of symptoms consistent with lung
cancer would lead to making an appointment with
the doctor was discussed. Across all groups, partici-
pants mentioned that if they believed symptoms were
severe enough (with an ensuing sense of urgency and
lack of alternate explanation) then they would go to
the doctor, but not because they thought they had
lung cancer. Participants qualified this by reporting
they know their body, and would know if something
was wrong.
“Life experience teaches us something, you know your
own body when you get to our age”. -65+, ex-S, metro
Haemoptysis and chest pain were the only symptoms
mentioned in all groups that would create a sense of ur-
gency. Symptoms such as dyspnoea were considered a
normal part of aging. A widely held view was that partic-
ipants would not discuss with their doctor a symptom
that they felt to be ‘mild’, on the assumption that mild
symptoms will ‘go away’.
“No, otherwise you’d be going to the doctor every day
of your life”. - 45–64, NS, metro
Barriers to help seeking
Many barriers to help-seeking were reported, including
current smokers admitting that they wouldn’t be ‘game’
to go to their doctor about such symptoms because of
feelings of stigma associated with smoking. As a result
there was a tendency to ‘wait and see’ how bad symp-
toms become before help-seeking. A sense of fatalism
amongst both current and former smokers about their
current and future health was also evident.
“If you know it’s self-inflicted, you’re less likely to go
until you really have to”. - 45–64, ex-S, regional
“Possibly a feeling that the doctor is going to focus on
your smoking “don’t bother coming back until you’ve
fixed your smoking”. - 65+, S, regional
Other barriers to help-seeking included difficulty in
accessing a general practitioner (GP), an issue men-
tioned by all of the regional groups, while the older age
groups were more inclined to wait until their next
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check-up. Fear of bad news was a common barrier
across most of the current and former smoker groups,
irrespective of age or socio-economic background.
Down-playing risk
There was an understanding amongst all participants
that smokers were more likely to develop lung cancer.
However, there was a strong rejection by smokers that
smoking was the only causal factor, with a conviction
across the groups of current smokers that “cancer
doesn’t discriminate”. Smokers down-played the magni-
tude of the risk due to smoking, providing other causal
reasons such as pollution, a stressful job, or blaming
‘newer’ manufactured cigarettes and their additives as
opposed to cigarettes smoked in their earlier years.
“We are so surrounded by many other toxins it’s
impossible to isolate cigarettes only”. - 65+, S, metro
Amongst current smokers, risk susceptibility was
down-played. No one felt immune, but dissonant views
were held about whether as smokers, they were more at
risk than anyone else.
“We know the facts, yet we still smoke. So we’re
obviously in denial about a lot of things. We can
accept one point of view and another, because we’re
playing mind games with ourselves”. - 50–64, S,
regional
In terms of reducing or balancing risk, smokers felt
that by offsetting smoking with other healthy behaviours
or smoking less they reduced their risk of lung cancer.
“By cutting down, eating well and living healthily I’m
reducing my risk”. - 50–64, S, regional
Former smokers generally felt that they were less sus-
ceptible to developing lung cancer, with many quoting
health messages which seemed to imply that their
chance of developing lung cancer would end after quit-
ting smoking.
“I have a feeling they say 10 years you come back, you
got it [the effects of smoking] out of your system”. - 40–
64, ex-S, regional
“They say after three months it’s already clearing”. -
65+, ex-S, metro
Uncertainty about cancer causation
Tied with perception of risk, was a broader uncertainty
and limited understanding of cancer. This was unrelated
to age, smoking status or socio-economic status. Lung
cancer was understood as something that was “on the
bad end of the cancer spectrum”, though largely confus-
ing, yet something that could be managed through such
actions as improving diet and exercise.
“The basic question is why does cancer strike one
person and not someone else? …Am I going to get it?
We used to think cancer was catching” - 65+, ex-S,
regional
“Can they trigger that down or narrow that down to
find out what disposition makes someone susceptible
to it or any other cancer?” - 45–64, ex-S, metro
“I think we all are (susceptible). I think it’s up us to
look after ourselves and get as much exercise” - 45–64,
NS, metro
Quantitative
The majority of survey participants were female
(61.2 %); aged >65 years (53.4 %); low socio-economic
status (52.9 %); and had a previous experience of cancer,
either their own or through a close relative/friend
(74.1 %); 14.1 % of the sample currently smoked, 45.9 %
were former smokers (Table 3).
Knowledge of risk factors
The majority of participants were able to identify smok-
ing as a risk factor for lung cancer (90.6 %, 95 % CI
88.4–92.8), however fewer recognised the risk of second-
hand smoke (25.6 %, 95 % CI 22.3–28.9) (Table 4).
When compared by smoking status, current smokers
were significantly less aware of the risk of lung cancer
due to second-hand smoke (AOR 0.4; 95 % CI: 0.2–0.7).
This inverse relationship (also observed in the qualitative
component) was evident across other risk factors with
current smokers more likely to mention factors such as
air pollution than never/former smokers (AOR 1.6; 95 %
CI: 1.0–2.5).
Symptom recognition
The majority of participants correctly identified between
one and three symptoms associated with lung cancer
(n = 820; 82.0 %); 6.5 % identified more than three,
while 11.5 % (n = 115) were unable to identify any
sentinel symptoms of lung cancer. The most recognised
symptoms were shortness of breath (55.5 %, 95 % CI
51.9–59.2) and coughing up of blood (39.1 %, 95 % CI
35.4–42.7) (Table 5). Again, these symptoms had also
been the most recognised in the focus group discussions.
Also, the majority of participants were able to recognise
the association between lung cancer and ‘a cough’ more
generally (54.8 % 95 % CI 51.1–58.5). No statistically
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significant differences were observed according to smok-
ing status.
In the multivariate analysis, males were significantly
less likely to recognise sentinel symptoms as warning
signs for lung cancer compared to females (failure to
recognise: AOR 2.07; 95 % CI: 1.20–3.59); while adults
younger than 65 years were significantly more likely to
recognise symptoms (AOR 0.55; 95 % CI: 0.33–0.91)
(Table 6). Analysis of all cough related symptoms
showed similar findings however age was no longer a
significant predictor in the sample population. Partici-
pants identified as current or former smokers were no
more or less likely to recognise sentinel symptoms. Sub-
analysis of these more at risk populations revealed no
significant differences in symptom awareness according
to pack-years of smoking.
Help-seeking behaviour
In contrast with the qualitative findings which suggested
a low confidence, the majority of the population sample
was very or fairly confident they would notice a symp-
tom of lung cancer (59 %). Confidence did not differ
across age, sex, SES, geographic or smoking status yet
was dependent upon ever having being diagnosed with
cancer in the past or having a close/friend or relative
who had been diagnosed with a cancer (unspecific)
(AOR 1.65; 95 % CI 1.09–2.48). The majority of partici-
pants (78 %) also reported they would see a doctor
within a week if they had a symptom they thought might
be associated with lung cancer, and there was no differ-
ence across demographic groups. There was however a
difference in terms of telling family/partner, with ever
smokers half as likely to tell a family member if they had







40-64 years 466 67.7
65 years and older 534 32.3
Index of relative socio-economic disadvantage:
1—3 (least disadvantaged) 529 53.5
4—5 (most disadvantaged) 470 46.5
Education/income combined into socio-economic status:
Lowest SES 355 39.2
Intermediate SES 138 18.7





Current smoker 141 11.8
Former smoker 459 30.5
Never smoked 400 57.8
Pack years of smoking:
Less than or equal to 10 pack years 157 54.0
More than 10 pack years 159 46.0
Total years of smoking:
Less than or equal to 20 years 286 48.9
More than 20 years 309 51.0
Previous experience of cancer:
Self/family/friend with cancer 741 74.5
No close cancer experience 257 25.5
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any symptoms they thought might be associated with
lung cancer (AOR 0.54; 95 % CI:0.37–0.81).
Discussion
Across both qualitative and quantitative findings, identi-
fication of symptoms and risk factors was consistent, yet
where the quantitative data provided correlations, the
qualitative responses helped to explain these associa-
tions. For example, smoking as a risk factor for lung
cancer was noted in the quantitative findings and quali-
tative findings, however some of the smoking groups ei-
ther avoided mentioned smoking as a risk factor or they
down-played the risk of smoking in discussing the risk
(Table 4 matrix). Similarly, under-recognition of the risk
of second-hand smoke, particularly in current smokers
was observed in the qualitative data and confirmed in
the quantitative analysis. These findings might suggest a low
perceived susceptibility of lung cancer amongst smokers.
Recognition of symptoms was similar across the quali-
tative and quantitative findings with most of the sample
recognising symptoms of haemoptysis and dyspnoea yet
some confusion between emphysema and lung cancer
observed in the focus groups study might explain the
high recognition of dyspnoea in the survey findings. We
had expected some variation in symptom recognition
based on smoking status however the quantitative com-
ponent indicated that current or former smokers were
no more or less likely to recognise symptoms. It is per-
haps unsurprising however that knowledge of symptoms
was lower in the older age group. Previous studies indi-
cate that older people are more likely to attribute symp-
toms to either ageing or co-morbidities [11] and as the
Table 4 Unprompted recognition of risk factors perceived to be associated with lung cancer by NSW residents, Australia, 2012 (n=1000)
(weighted to NSW population) and triangulation with qualitative focus group data


















90.6 (88.4-92.8) 86.6 89.7 91.9 No observed differences
between group discussions
based on age, geography.
13 groups mention
smoking, those that
didn’t were all smoker
groups
The link with smoking is
very well known and people
just ignore that and just
keep on coughing away.
Second-hand
smoke
25.6 (22.3-28.9) 14.4** 23.3 * 29.1 7 groups mention
passive smoking,
those that didn’t were
current/exsmoker
I think certain people are
more allergic to nicotine
than what otherpeople are.
Air pollution 21.6 (18.5-24.8) 28.1 * 22.3 20.0 The majority of
discussions focused
around smoking as a
cause and its comparability
to other potential factors.
11 groups mention
air pollution
Look if you’re taking anything
into your lungs which isn’t
clean air, obviously that’s
going to have some e effect.
Chemicals &
sprays
24.4 (21.1-27.6) 30.8 23.9 23.3 7 groups mention
chemical substances
such as poisons, dyes,
fertilisers
Probably the toothpaste
has worse chemicals than
all of them.
Asbestos 15.3 (12.6-17.9) 17.3 12.4 16.4 There was confusion about
whether it was chance





Like asbestos and that …
anything that can affect the
lungs and your breathing.
Occupational
exposure
4.9 (3.1-6.7) 2.6 3.9 5.9 8 groups mention
occupation
People working in coal
mines could be at risk of
lung disease. People working
at a chemical plant.
Hereditary 13.1 (10.8-15.8) 16.9 14.2 12.2 All groups mention a
‘genetic predisposition’
I do believe that everybody
is carrying a cancer gene
but it has to have
something to activate it.
Unhealthy
lifestyle




Yeah, exactly, and I think if
a lot of us paid more
attention to our fitness,
maybe cancer wouldn’t
be quite so common.
Diet 7.0 (5.0-9.0) 5.1 3.5 * 9.3 9 groups believe diet
is a cause of lung
cancer
Food and diet additives,
preservatives, chemicals
in food.
*p<0.05 **p<0.01 (reference group - never smoker) Factors mentioned but having no known association in italics
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risk of co-morbidity increases with age, difficulty in dif-
ferentiating symptoms is also likely to increase. Similarly
lower recognition of symptoms has been found in other
studies, suggesting that men have a lower cancer aware-
ness, poorer knowledge of cancer warning signs, less fre-
quent contact with doctors and are thus more likely to
delay in symptom presentation [33]. Greater confidence in
recognising symptoms was associated with knowing some-
one who had been diagnosed with any type of cancer.
The ability to recognise a sentinel symptom for lung
cancer appears high compared with findings in the UK
[25]. However our qualitative study suggested that while
symptom knowledge may appear high, many people
would delay seeking help for symptoms. A low self-
perceived risk and ‘wait and see’ attitude was prevalent
across groups despite belief in both study components
that if the person had symptom suggestive of lung can-
cer they would seek help promptly. These findings sug-
gest that immediate help-seeking behaviours would not
occur unless the symptom was considered serious, such
as coughing up blood. These findings are consistent with
evidence across cancer types, suggesting many patients
may underestimate the urgency, attribute mild symp-
toms to common ailments or believe symptoms will go
away [14]. This assumption that only major symptoms
warrant medical attention has implications for
prompting earlier diagnosis. While mild symptoms may
be more likely to be ignored, they may be more common
in initial stages of the disease [19] when surgical resec-
tion may offer better survival outcomes [5]. Other po-
tential factors for delay in seeking medical help
mentioned in the focus groups include difficulty in
accessing a GP, particularly for people living in regional
and rural locations [34]. Current and former smokers
also expressed fear of judgement or blame as reasons for
currently delaying GP visits. Unsurprisingly, reluctance
to seek medical attention due to stigma around smoking
has been described elsewhere as a reason people at risk
of lung cancer delay presentation [17, 35]. There is
therefore an important role for family and extended so-
cial networks in supporting these individuals to act upon
their symptoms [36] and a critical role for health profes-
sionals in taking a no blame approach when interacting
with current and former smokers.
This study is unique in that it considers evidence from
both qualitative and quantitative studies, providing a
richer understanding of the current community aware-
ness of lung cancer. Without the qualitative findings the
evidence would suggest people living in NSW have a
reasonable understanding of lung cancer symptoms.
However, the qualitative findings reveal that despite
awareness of cancer symptoms and risks, high-risk
Table 5 Unprompted recognition of symptom of lung cancer by NSW residents, Australia, 2012 (n=1000) (weighted to NSW
population) and triangulation with qualitative focus group data
Quantitative survey responses Qualitative focus group responses

















23.6 (20.4-26.8) 26.5 21.6 24.1 Most understood that these
symptoms could be typical of






able to be specific
There’s cough and there’s
cough…when you’re
persistently [coughing]
it’s a sign of cancer.
Worsening
cough
6.3 (4.5-8.1) 5.3 6.3 6.5 The kind of cough that
comes from way down.
A persistent
cough
17.0 (14.3-19.7) 14.6 19.0 16.5 A persistent cough, non-stop,
sort of thing. It’s been on for
days and weeks on end.
Persistent
chest infection





39.1 (35.4-42.7) 43.5 37.9 38.8 All groups
mention symptom
You can cough up blood and
that’s something else, probably.
Shortness
of breath
55.5 (51.9-59.2) 56.5 54.9 55.7 Most groups
mention symptom
On the ad on telly they say
you can hear lung cancer
before you can see it.
Chest pain 10.4 (8.1-12.7) 9.8 10.4 10.4 Most groups
mention symptom





3.0 (1.8-4.3) 1.3 3.4 3.2 4 groups mentioned
weight loss, only one,
mentions appetite
A dramatic loss of weight.
Crane et al. BMC Public Health  (2016) 16:508 Page 9 of 12
Table 6 Logistic regression modelling of symptom recognition of lung cancer on demographic predictors in a sample of residents in NSW, Australia, 2012 (n=1000)
Failure to recognize any symptom Failure to recognise cough
All participants Smokers only All participants Smokers only
N Odds ratio 95 % CI p value Odds ratio 95 % CI p value Odds ratio 95 % CI p value Odds ratio 95 % CI p value
Age group:
65 years and older 677 1 1 1 1
40-64 years 323 0.55 0.33-0.91 0.02 0.27 0.15-0.52 0.000 0.85 0.59-1.21 0.4 0.63 0.40-0.98 0.05
Sex:
Female 544 1 1 1 1
Male 456 2.07 1.20-3.59 0.009 1.70 0.93-3.09 0.08 1.59 1.11-2.27 0.01 1.48 0.97-2.27 0.07
Smoking status (2 categories):
Never smoked 578 1 - - - 1 - - -
Ever smoked daily or weekly 422 0.76 0.45-1.27 0.7 1.04 0.73-1.47 0.8 0.7
Index of relative socio-economic disadvantage:
1—3 (least disadvantaged) 535 1 1 1 1 0.7
4—5 (most disadvantaged) 465 0.87 0.43-1.79 0.7 1.03 0.42-2.52 0.9 0.93 0.59-1.46 0.7 0.89 0.53-1.52
Education/income combined into socio economic status:
Lowest SES 289 1 1 1 1
Intermediate SES 138 0.68 0.34-1.42 0.3 0.57 0.26-1.26 0.2 1.46 0.91-2.35 0.1 1.47 0.80-2.71 0.2
Highest SES 311 0.62 0.33-0.19 0.2 0.65 0.29-1.43 0.3 0.99 0.64-1.53 0.9 0.97 0.57-1.66 0.9
Previous experience of cancer:
Self/family/friend with cancer 744 1 1 1 1
No close cancer experience 255 0.83 0.46-1.50 0.5 1.28 0.68-2.40 0.4 0.77 0.51-1.15 0.2 1.34 0.88-2.12 0.2
Location based on final postcode:
Regional 401 1 1 1 1
Metropolitan 599 1.47 0.72-3.001 0.3 2.11 0.81-5.44 0.1 1.51 0.96–2.38 0.08 1.62 1.0–2.6 0.08
Years of smoking:
Less than or equal to 20 years 291 - - - 1 - - - 1
More than 20 years 304 1.80 0.96-3.36 0.07 1.37 0.88–2.12 0.2
Goodness of fit test for model 0.390 0.191 0.236 0.678














individuals have poor perceptions about their personal
risk and the seriousness of sentinel symptoms. While de-
nial was high amongst current smokers, former heavy
smokers might also have a false sense of security, with
qualitative findings suggesting that public health mes-
sages about the benefits of quitting may have been
interpreted as implying that the risk of lung cancer
disappears on quitting.
In an attempt to reduce patient related delays to diag-
nosis, public health approaches which challenge poor
perceptions of personal risk may have a significant po-
tential to improve lung cancer outcomes for those most
at risk. Potential public health approaches include the
implementation of public education campaigns for the
general population which outline key signs and symp-
toms of lung cancer. This is supported by the evaluation
of a large-scale public awareness campaign in the UK
which demonstrated an improvement in both knowledge
of symptoms and lung cancer stage distribution follow-
ing a sentinel symptom awareness campaign [10, 37]. In
addition, complimentary public health messages to tar-
get individuals at high-risk of developing lung cancer
would be beneficial given the disparity in knowledge and
perceived risk. However, the fears of stigma indicate that
health professionals interacting with current and former
smokers would need to be well prepared to provide a
safe and non-blaming environment for those presenting
with symptoms suggestive of lung cancer.
The limitations of this study are that investigating
population awareness of lung cancer signs and symp-
toms relied on cross-sectional data and hypothetical sce-
narios to explore help-seeking behaviours and to model
symptoms. Longitudinal studies or case studies with
lung cancer patients and assessment of disease staging
would be needed to verify findings. In terms of sampling,
the use of RDD sampling frame will have resulted in ex-
clusion of mobile phone-only households which may
have an effect on selection bias. We sought to minimise
this through higher sampling of ever smokers given
current smokers have a higher tendency to live in
mobile-only households in Australia. The qualitative
data may also have been limited in that the researchers
were not present at all of the focus group sessions and
focus group participants were not recontacted to validate
comments made during the group discussion. The re-
sults may be ungeneralisable given the potential differ-
ences in exposure to messages relating to lung cancer.
Conclusion
Drawing on insights from qualitative and quantitative
sources, this study found that while awareness of lung
cancer symptoms and causative factors may seem reason-
ably well understood in the community, perceived suscep-
tibility is low, particularly amongst those most at risk. A
lack of urgency in help-seeking for symptoms considered
mild and therefore trivial, together with smoking-related
barriers such as stigmatism and nihilism, may contribute
to delay in diagnosis and poorer outcomes.
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